Innovative Technique for Oxygen Delivery Gains Attention
The concept might sound bizarre enough to earn an IgNobel prize back in 2024, yet the underlying science is quite serious. It’s about rescuing individuals with blocked airways and compromised lungs through rectal delivery of oxygen, commonly referred to as “enteral ventilation.” This isn’t just a joke; there’s real research backing it up.
Recent findings, published in the journal Med, detail the first human clinical trial focusing on this technique. Takanori Takebe, MD, Ph.D., a prominent figure in organoid research at Cincinnati Children’s and the University of Osaka, explains, “This initial data only confirms the safety of the procedure, not its effectiveness. However, having established that it’s tolerable, we can now look into how effective it truly is at delivering oxygen to the bloodstream.”
Understanding Enteral Ventilation
This idea proposes a method similar to an enema, utilizing a special, oxygen-rich liquid to deliver crucial oxygen into the bloodstream via the colon.
A pivotal study highlighted some preliminary findings on a porcine model, which was showcased on the cover of Med in 2021 and later featured in the popular Canadian science show, “The Nature of Things.” This foundational work led to Takebe and his team’s recognition when they received the IgNobel Prize in 2024.
If the ongoing human trials are successful, this straightforward approach could provide a new means for hospitals to assist patients facing airway blockages due to injuries or infections that severely hinder lung function.
A Concept with Deep Roots
The technique draws inspiration partly from the loach, a bottom-dwelling fish that can sip air and absorb oxygen through its gut, allowing it to thrive in low-oxygen environments.
Additionally, it builds on the research of former Cincinnati Children’s researcher Leland Clark, Ph.D., who developed a perfluorocarbon liquid known as Oxycyte. While the product didn’t advance as a potential artificial blood alternative, it gained fame in the 1989 film “The Abyss,” featuring a scene where a rat appeared to “breathe” this liquid.
Findings and Future Directions
The recent study involved 27 healthy men in Japan who were asked to hold different quantities of perfluorocarbon liquid (without oxygen) for an hour. Twenty participants managed to hold the liquid for the full 60 minutes, some up to 1,500 ml. While the larger volumes caused some bloating and discomfort, no significant adverse effects were noted.
The next critical step will be to test the oxygenated version of the liquid, determining how much needs to be administered and for how long to effectively raise blood oxygen levels. Ultimately, Takebe and his team are keen to expand this technology for use in caring for newborns.
Takebe, who has established a company called EVA Therapeutics for this initiative, mentions that the timeline for the next clinical trial will depend on fundraising efforts.
